CLARIS BIOTHERAPEUTICS
Claris Biotherapeutics develops a topical formulation intended to cure corneal wounds, ulcers, and scars. The formulation creates a recombinant hepatocyte growth factor which accelerates the healing process, providing healthcare providers noninvasive therapeutic treatment.
CLARIS BIOTHERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2018-01-01
Address:
Jersey City, New Jersey, United States
Country:
United States
Total Employee:
1+
Status:
Closed
Total Funding:
38.5 M USD
Current Employees Featured
Founder
